The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness

Cell Cycle

Volumn 12, Issue 21, 2013, Pages 3405-3420

  Sisci, Diego ^a   Maris, Pamela ^b   Cesario, Maria Grazia ^a   Anselmo, Wanda ^a,c   Coroniti, Roberta ^a,d   Trombino, Giovanna Elvi ^a   Romeo, Francesco ^e   Ferraro, Aurora ^e   Lanzino, Marilena ^a   Aquila, Saveria ^a   Maggiolini, Marcello ^a   Mauro, Loredana ^e   Morelli, Catia ^a   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e Annunziata Hospital   (Italy)

Author keywords

Breast cancer; Estrogen receptor; Forkhead transcription factors; Invasion; Motility

Indexed keywords

CAVEOLIN 1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHRL1;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CANCER; CANCER INHIBITION; CARCINOMA IN SITU; CAVEOLA; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; METASTASIS; PHENOTYPE; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TUMOR INVASION; UPREGULATION;

BREAST CANCER; ESTROGEN RECEPTOR; FORKHEAD TRANSCRIPTION FACTORS; INVASION; MOTILITY;

AGED; BINDING SITES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CAVEOLIN 1; CELL LINE, TUMOR; CELL MOVEMENT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PROTEIN BINDING; RESPONSE ELEMENTS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84887977769     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26421     Document Type: Article

References (44)

1. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005;24:7410-25; PMID:16288288; http://dx.doi.org/10.1038/sj.onc.1209086 (Pubitemid 41637981)
2. Yang JY, Hung MC. Deciphering the role of forkhead transcription factors in cancer therapy. Curr Drug Targets 2011;12:1284-90; PMID:21443462; http://dx.doi.org/10.2174/138945011796150299
3. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004;117:225-37; PMID:15084260; http://dx.doi.org/10.1016/S0092-8674 (04) 00302-2 (Pubitemid 38496242)
4. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008;10:138-48; PMID:18204439; http://dx.doi.org/10.1038/ncb1676 (Pubitemid 351194043)
5. Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res 2008;10:R21; PMID:18312651; http://dx.doi.org/10.1186/bcr1872
6. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007;128:309-23; PMID:17254969; http://dx.doi.org/10.1016/j.cell.2006.12.029 (Pubitemid 46123514)
7. Sisci D, Surmacz E. Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. Curr Pharm Des 2007;13:705-17; PMID:17346185; http://dx.doi.org/10.2174/138161207780249182 (Pubitemid 46510746)
8. Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Andò S, Sisci D. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets 2008;8:597-610; PM ID:18 9 91569; http://dx.doi.org/10.2174/156800908786241104
9. Schuur ER, Loktev AV, Sharma M, Sun Z, Roth RA, Weigel RJ. Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family. J Biol Chem 2001;276:33554-60; PMID:11435445; http://dx.doi.org/10.1074/jbc. M105555200
10. Zhao HH, Herrera RE, Coronado-Heinsohn E, Yang MC, Ludes-Meyers JH, Seybold-Tilson KJ, Nawaz Z, Yee D, Barr FG, Diab SG, et al. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J Biol Chem 2001;276:27907-12; PM ID:11353774; http://dx.doi.org/10.1074/jbc. M104278200
11. Morelli C, Lanzino M, Garofalo C, Maris P, Brunelli E, Casaburi I, Catalano S, Bruno R, Sisci D, Andò S. Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells. Mol Cell Biol 2010;30:857-70; PMID:19933843; http://dx.doi.org/10.1128/MCB.00824-09
12. Belguise K, Guo S, Sonenshein GE. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 2007;67:5763-70; PMID:17575143; http://dx.doi.org/10.1158/0008-5472. CAN-06-4327 (Pubitemid 46985009)
13. Storz P, Döppler H, Copland JA, Simpson KJ, Toker A. FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. Mol Cell Biol 2009;29:4906-17; PMID:19564415; http://dx.doi.org/10.1128/MCB.00077-09
14. Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, Cunat S, Garcia M. Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 1998;65:163-8; PMID:9699869; http://dx.doi.org/10.1016/S0960-0760 (98) 00010-7 (Pubitemid 28335602)
15. Sisci D, Middea E, Morelli C, Lanzino M, Aquila S, Rizza P, Catalano S, Casaburi I, Maggiolini M, Andò S. 17β-estradiol enhances α (5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells. Breast Cancer Res Treat 2010;124:63-77; PMID:20052536; http://dx.doi.org/10.1007/ s10549-009-0713-6
16. Manni A, Wright C, Buck H. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res Treat 1991;20:43-52; PMID:1813068; http://dx.doi.org/10.1007/BF01833356
17. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55-67; PMID:15207254; http://dx.doi.org/10.1016/ j.critrevonc.2004.02.001 (Pubitemid 38781751)
18. Van Den Heuvel AP, Schulze A, Burgering BM. Direct control of caveolin-1 expression by FOXO transcription factors. Biochem J 2005;385:795-802; PMID:15458387; http://dx.doi.org/10.1042/BJ20041449 (Pubitemid 40208841)
19. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 2000;60:5977-83; PM ID:11085516
20. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 2002;16:100-15; PMID:11773442; http://dx.doi.org/10. 1210/me.16.1.100 (Pubitemid 34044501)
21. Sloan EK, Stanley KL, Anderson RL. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 2004;23:7893-7; PMID:15334058; http://dx.doi.org/10.1038/sj.onc.1208062 (Pubitemid 39457039)
22. Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H, et al. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res 2008;68:8210-20; PMID:18922892; http://dx.doi.org/10.1158/ 0008-5472. CAN-08-0343
23. Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG, Lisanti MP. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Res 2006;66:10647-51; PMID:17108100; http://dx.doi.org/10.1158/0008-5472. CAN-06-2805 (Pubitemid 44876957)
24. Fiucci G, Ravid D, Reich R, Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 2002;21:2365-75; PMI D:119484 20; http://dx.doi.org/10. 1038/sj.onc.1205300 (Pubitemid 34413560)
25. Wu P, Wang X, Li F, Qi B, Zhu H, Liu S, Cui Y, Chen J. Growth suppression of MCF-7 cancer cellderived xenografts in nude mice by caveolin-1. Biochem Biophys Res Commun 2008;376:215-20; PMID:18778685; http://dx.doi.org/10.1016/j. bbrc.2008.08.146
26. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004;279:51630-46; PMID:15355971; http://dx.doi.org/10. 1074/jbc. M409214200 (Pubitemid 40017914)
27. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006;38:1289-97; PMID:17013392; http://dx.doi.org/10.1038/ng1901 (Pubitemid 44646291)
28. Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008;41:263-75; PMID:18772268; http://dx.doi.org/10.1677/JME-08-0103
29. Lützner N, De-Castro Arce J, Rösl F. Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors. PLoS One 2012;7:e32590; PMID:22412893; http://dx.doi.org/10.1371/journal.pone. 0032590
30. Luo X, Puig O, Hyun J, Bohmann D, Jasper H. Foxo and Fos regulate the decision between cell death and survival in response to UV irradiation. EMBO J 2007;26:380-90; PMID:17183370; http://dx.doi.org/10.1038/sj.emboj.7601484 (Pubitemid 46160939)
31. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulusdependent transcription of c-fos. Mol Cell Biol 1998;18:967-77; PMID:9447994 (Pubitemid 28063431)
32. Simonis M, Kooren J, De Laat W. An evaluation of 3C-based methods to capture DNA interactions. Nat Methods 2007;4:895-901; PMID:17971780; http://dx.doi.org/10.1038/nmeth1114 (Pubitemid 350042374)
33. Abbondanza C, De Rosa C, Ombra MN, Aceto F, Medici N, Altucci L, Moncharmont B, Puca GA, Porcellini A, Avvedimento EV, et al. Highlighting chromosome loops in DNA-picked chromatin (DPC). Epigenetics 2011;6:979-86; PMID:21725198; http://dx.doi.org/10.4161/epi.6.8.16060
34. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005;122:33-43; PMID:16009131; http://dx.doi.org/10.1016/j. cell.2005.05.008 (Pubitemid 40977938)
35. Van Den Eynden GG, Van Laere SJ, Van Der Auwera I, Merajver SD, Van Marck EA, Van Dam P, Vermeulen PB, Dirix LY, Van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 2006;95:219-28; PMID:16244790; http://dx.doi.org/10.1007/s10549-005-9002-1
36. Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, James M, Hornick JL, Pereira EM, Milanezi F, et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res 2007;13:90-101; PMID:17200343; http://dx.doi.org/10. 1158/1078-0432. CCR-06-1371 (Pubitemid 46121857)
37. Elsheikh SE, Green AR, Rakha EA, Samaka RM, Ammar AA, Powe D, Reis-Filho JS, Ellis IO. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 2008;99:327-34; PMID:18612310; http://dx.doi.org/10.1038/sj.bjc.6604463
38. Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res 2009;69:8594-602; PM ID:19887621; http://dx.doi.org/10.1158/0008-5472. CAN-09-2305
39. Jin GS, Kondo E, Miyake T, Shibata M, Takashima T, Liu YX, Hayashi K, Akagi T, Yoshino T. Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. Acta Med Okayama 2004;58:197-205; PMID:15551757 (Pubitemid 39277936)
40. Bertos NR, Park M. Breast cancer - one term, many entities? J Clin Invest 2011;121:3789-96; PMID:21965335; http://dx.doi.org/10.1172/JCI57100
41. Habashy HO, Rakha EA, Aleskandarany M, Ahmed MA, Green AR, Ellis IO, Powe DG. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Res Treat 2011;129:11-21; PMID:21336599; http://dx.doi.org/10.1007/s10549-010-1161-z
42. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers W R. A novel mechanism of gene regu lation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002;2:81-91; PMID:12150827; http://dx.doi.org/10.1016/S1535- 6108 (02) 00086-7 (Pubitemid 41043990)
43. Cao S, Fernandez-Zapico ME, Jin D, Puri V, Cook TA, Lerman LO, Zhu XY, Urrutia R, Shah V. KLF11-mediated repression antagonizes Sp1/sterolresponsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem 2005;280:1901-10; PMID:15531587; http://dx.doi.org/10.1074/jbc. M407941200
44. Lanzino M, Sisci D, Morelli C, Garofalo C, Catalano S, Casaburi I, Capparelli C, Giordano C, Giordano F, Maggiolini M, et al. Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element. Nucleic Acids Res 2010;38:5351-65; PMID:20421209; http://dx.doi.org/10.1093/nar/gkq278